跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
优立新 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ampicillin Sodium and Sulbactam Sodium for Injection
Approved
化学药品
Ampicillin Sodium and Sulbactam Sodium for Injection
Pfizer Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jun 28, 2021
Approval ID
8BYtZ2JSHtE
Company
Pfizer Pharma GmbH
Type
化学药品
Approval Details
Approval Id
8BYtZ2JSHtE
Approval Number
国药准字HJ20160571
Generic Name
注射用氨苄西林钠舒巴坦钠
Generic Name En
Ampicillin Sodium and Sulbactam Sodium for Injection
Trade Name
优立新
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.75g（C₁₆H₁₉N₃O₄S 0.50g与C₈H₁₁NO₅S 0.25g）
Reg Date
2021-06-28
Expired Date
2026-06-27
Company Name
Pfizer Pharma GmbH
Production Company Name
HAUPT PHARMA LATINA SRL
Company Detail Path
/organization/pfizer-pharma-gmbh
Production Company Detail Path
/organization/haupt-pharma-latina-srl
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 28, 2021
Approval ID
8BYtZ2JSHtE
Type
化学药品
Back to NMPA Approvals
